Dr. Mohammad Mobashir
Researcher, Department of Biomedical, Laboratory Science, NTNU Norwegian University of Science and Technology, Norway, United States
IMPARC ID: IMP-MM-BIO-NO-2026-2261
Profile Summary
Dr. Mohammad Mobashir is a Ph.D. in Biochemistry (Immunology) with extensive research and teaching experience in cancer systems biology, personalized medicine, immunology, and biochemistry. He earned his Ph.D. from Otto-von-Guericke University, Germany, with research focused on mathematical modeling and evolution of signal transduction pathways and networks.
He is currently working as a Researcher at the Department of Biomedical Laboratory Science, NTNU (Norwegian University of Science and Technology), Norway, and has been serving as an Assistant Professor at King Abdulaziz University, Saudi Arabia. He has also worked as a Postdoctoral Researcher at Karolinska Institute, Sweden, and Otto-von-Guericke University, Germany.
Dr. Mobashir has authored 49 research articles with a total impact factor of 135.151 and an H-index of 14. His research integrates computational systems biology, cancer biology, gene expression profiling, pathway modeling, immunology, and high-throughput data analysis. He has supervised Ph.D., Master’s, and Bachelor’s students and has significant experience in systems biology, OMICs-based diagnostics, and biostatistics teaching.
Subject Matter Expertise
Subject Matter Expertise:
Healthcare & Medicine
→ Cancer Research
– Cancer Biology
→ Medicine
– Oncology
→ Allergy & Clinical Immunology
– Clinical Immunology
STEM
→ Biology / Life Sciences
– Molecular Biology
– Biochemistry
– Biotechnology & Bioengineering
→ Data Science
– Bioinformatics
– Data Analysis (Machine Learning)
Healthcare & Medicine
→ Cancer Research
– Cancer Biology
→ Medicine
– Oncology
→ Allergy & Clinical Immunology
– Clinical Immunology
STEM
→ Biology / Life Sciences
– Molecular Biology
– Biochemistry
– Biotechnology & Bioengineering
→ Data Science
– Bioinformatics
– Data Analysis (Machine Learning)
Mentorship Offered
Services Offered:
Research
– Scientific and Technical Research
– Systematic Literature Review
Data & AI
– Big Data Analytics
– Predictive Modeling
– Algorithm Design – ML (Machine Learning)
Writing
– Technical Writing
Research
– Scientific and Technical Research
– Systematic Literature Review
Data & AI
– Big Data Analytics
– Predictive Modeling
– Algorithm Design – ML (Machine Learning)
Writing
– Technical Writing
Work Experience Summary
Dr. Mohammad Mobashir has held research and academic positions across Europe and the Middle East. He is currently a Researcher at NTNU, Norway, and an Assistant Professor at King Abdulaziz University, Saudi Arabia. Previously, he worked as a Postdoctoral Researcher at Karolinska Institute (Sweden) and Otto-von-Guericke University (Germany), focusing on tumor biology, immunology, inflammation, prostate cancer heterogeneity, and signal transduction modeling.
Work Experience:
Company Name: NTNU (Norwegian University of Science and Technology), Trondheim, Norway
Job Title: Researcher
Duration: May 2023 – Present
Company Name: King Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia
Job Title: Assistant Professor, Special Infectious Agents Unit
Duration: May 2018 – Present
Company Name: Karolinska Institute, Department of Microbiology, Tumor and Cell Biology, Stockholm, Sweden
Job Title: Postdoctoral Researcher
Duration: February 2016 – Present (as per CV listing)
Company Name: SciLifeLab, Karolinska Institute, Stockholm, Sweden
Job Title: Postdoctoral Fellow
Duration: June 2014 – September 2015
Company Name: Otto-von-Guericke University, Magdeburg, Germany
Job Title: Postdoctoral Fellow
Duration: July 2013 – June 2014
Company Name: NTNU (Norwegian University of Science and Technology), Trondheim, Norway
Job Title: Researcher
Duration: May 2023 – Present
Company Name: King Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia
Job Title: Assistant Professor, Special Infectious Agents Unit
Duration: May 2018 – Present
Company Name: Karolinska Institute, Department of Microbiology, Tumor and Cell Biology, Stockholm, Sweden
Job Title: Postdoctoral Researcher
Duration: February 2016 – Present (as per CV listing)
Company Name: SciLifeLab, Karolinska Institute, Stockholm, Sweden
Job Title: Postdoctoral Fellow
Duration: June 2014 – September 2015
Company Name: Otto-von-Guericke University, Magdeburg, Germany
Job Title: Postdoctoral Fellow
Duration: July 2013 – June 2014
Educational Summary
Dr. Mobashir holds a Ph.D. in Biochemistry from Otto-von-Guericke University, Germany. He also earned an M.Sc. in Molecular Life Science from Jacobs University Bremen, Germany, an M.Sc. in Bioinformatics from Jamia Millia Islamia, India, and a B.Sc. in Chemistry, Botany, and Zoology from Magadh University, India.
Education:
Institution Name: Otto-von-Guericke University, Magdeburg, Germany
Degree Title: Ph.D.
Field/Description: Biochemistry (Mathematical Modeling and Evolution of Signal Transduction Pathways and Networks)
Duration: August 2010 – June 2013
Institution Name: Jacobs University Bremen, Germany
Degree Title: M.Sc.
Field/Description: Molecular Life Science (Molecular Biophysics and Computational Systems Biology)
Duration: September 2008 – August 2010
Institution Name: Jamia Millia Islamia, New Delhi, India
Degree Title: M.Sc.
Field/Description: Bioinformatics
Duration: July 2004 – July 2006
Institution Name: Magadh University, Bodh-Gaya, Bihar, India
Degree Title: B.Sc.
Field/Description: Chemistry (Main), Botany, Zoology
Year: 2004
Institution Name: Otto-von-Guericke University, Magdeburg, Germany
Degree Title: Ph.D.
Field/Description: Biochemistry (Mathematical Modeling and Evolution of Signal Transduction Pathways and Networks)
Duration: August 2010 – June 2013
Institution Name: Jacobs University Bremen, Germany
Degree Title: M.Sc.
Field/Description: Molecular Life Science (Molecular Biophysics and Computational Systems Biology)
Duration: September 2008 – August 2010
Institution Name: Jamia Millia Islamia, New Delhi, India
Degree Title: M.Sc.
Field/Description: Bioinformatics
Duration: July 2004 – July 2006
Institution Name: Magadh University, Bodh-Gaya, Bihar, India
Degree Title: B.Sc.
Field/Description: Chemistry (Main), Botany, Zoology
Year: 2004
Awards & Recognition
Dr. Siddiqui has demonstrated academic eligibility and research competence through nationally recognized certifications and continuous professional development programs.
International Awards:
Title: Travel Grant Fellowship Award
Event: Integrative Network Biology 2012: Network Medicine
Location: Helsingoer, Denmark
Date: May 2012
Title: Jacobs University Fellowship
Purpose: Study in Molecular Life Science (Computational Biology)
Institution: Jacobs University Bremen, Germany
Duration: September 2008 – August 2010
Title: Travel Grant Fellowship Award
Event: International Biomedical Modeling School and Workshop
Location: Bangalore, India
Date: February 2008
Conferences & Symposiums:
Event: Ernst Klenk Symposium in Molecular Medicine
Location: Köln, Germany
Date: 29 September – 01 October 2013
Event: Integrative Network Biology 2012: Network Medicine
Contribution: Poster Presentation
Location: Helsingoer, Denmark
Date: 2012
Event: International Biomedical Modeling School and Workshop
Contribution: Poster Presentation
Location: Bangalore, India
Date: 2008
Event: KI (Karolinska Institute) Annual Symposia
Location: Stockholm, Sweden
Date: 2014 – 2018
Event: International Conference on Theoretical Physics and Neuroscience
Location: Bremen, Germany
Date: 2009
Supervision of Students:
Ph.D. Supervision:
– Supervised Ph.D. students: Kholod (KSA), S. T. Anwer (JMI), Bushra Khan (JMI), Fazlur Rahman (JMI)
Master’s & Bachelor’s Supervision:
– Supervised more than 30 Master’s and Bachelor’s theses
Title: Mathematical Modeling of Normal and Cancer Prostate Signaling Pathways
Student: Ms. Sofia Stamouli (M.Sc. Bioinformatics, Uppsala University)
Duration: 03 November 2014 – 12 June 2015
Additional Scientific Roles:
Executive Editor:
– Combinatorial Chemistry and High Throughput Screening (CCHTS)
– Pharmaceuticals (MDPI)
– Frontiers in Biosciences
Guest Editor:
– Pharmaceuticals (MDPI)
Since: 22 December 2022
Associate Editor:
– Discover Oncology
– Frontiers in Biosciences
Reviewer:
– Nature
– Elsevier Journals
– Bentham Science
– Frontiers Journals
– MDPI Journals
– PLOS
– British Journal of Cancer (BJC)
– World Journal of Surgical Oncology (WJSO)
– Bioengineering
– BMC Journals
Title: Travel Grant Fellowship Award
Event: Integrative Network Biology 2012: Network Medicine
Location: Helsingoer, Denmark
Date: May 2012
Title: Jacobs University Fellowship
Purpose: Study in Molecular Life Science (Computational Biology)
Institution: Jacobs University Bremen, Germany
Duration: September 2008 – August 2010
Title: Travel Grant Fellowship Award
Event: International Biomedical Modeling School and Workshop
Location: Bangalore, India
Date: February 2008
Conferences & Symposiums:
Event: Ernst Klenk Symposium in Molecular Medicine
Location: Köln, Germany
Date: 29 September – 01 October 2013
Event: Integrative Network Biology 2012: Network Medicine
Contribution: Poster Presentation
Location: Helsingoer, Denmark
Date: 2012
Event: International Biomedical Modeling School and Workshop
Contribution: Poster Presentation
Location: Bangalore, India
Date: 2008
Event: KI (Karolinska Institute) Annual Symposia
Location: Stockholm, Sweden
Date: 2014 – 2018
Event: International Conference on Theoretical Physics and Neuroscience
Location: Bremen, Germany
Date: 2009
Supervision of Students:
Ph.D. Supervision:
– Supervised Ph.D. students: Kholod (KSA), S. T. Anwer (JMI), Bushra Khan (JMI), Fazlur Rahman (JMI)
Master’s & Bachelor’s Supervision:
– Supervised more than 30 Master’s and Bachelor’s theses
Title: Mathematical Modeling of Normal and Cancer Prostate Signaling Pathways
Student: Ms. Sofia Stamouli (M.Sc. Bioinformatics, Uppsala University)
Duration: 03 November 2014 – 12 June 2015
Additional Scientific Roles:
Executive Editor:
– Combinatorial Chemistry and High Throughput Screening (CCHTS)
– Pharmaceuticals (MDPI)
– Frontiers in Biosciences
Guest Editor:
– Pharmaceuticals (MDPI)
Since: 22 December 2022
Associate Editor:
– Discover Oncology
– Frontiers in Biosciences
Reviewer:
– Nature
– Elsevier Journals
– Bentham Science
– Frontiers Journals
– MDPI Journals
– PLOS
– British Journal of Cancer (BJC)
– World Journal of Surgical Oncology (WJSO)
– Bioengineering
– BMC Journals
Publication Summary
Dr. Mobashir has published 49 research articles in peer-reviewed international journals, with an H-index of 14. His publications focus on cancer systems biology, immunology, gene expression profiling, network biology, pathway modeling, diabetes, infectious diseases, and therapeutic targets. He has published in journals such as PLOS ONE, Scientific Reports, European Journal of Medicinal Chemistry, Frontiers journals, Cells, Biomedicines, International Journal of Molecular Sciences, and Pharmaceutics.
Publications (Selected):
Title: Simulated Evolution of Signal Transduction Networks
Authors: Mobashir M**, Schraven B, Beyer T
Journal: PLOS ONE, 7(12): e50905
Year: 2012
Impact Factor: 3.752
Title: Negative Interactions and Feedback Regulations are Required for Transient Cellular Response
Authors: Mobashir M**, Thati M, Isermann B, Beyer T, Schraven B
Journal: Scientific Reports, 4, 3718
Year: 2014
Impact Factor: 4.996
Title: Pivotal Role of Glycogen Synthase Kinase-3: A Therapeutic Target for Alzheimer’s Disease
Authors: Maqbool M, Mobashir M, Hoda N
Journal: European Journal of Medicinal Chemistry
Year: 2015
Impact Factor: 7.088
Title: Proactive for Invasion: Reuse of Matrix Metalloproteinase for Structural Memory
Authors: Gucciardo E, Mobashir M, Lehti K
Journal: Journal of Cell Biology, 213(1):11–13
Year: 2016
Impact Factor: 10.539
Title: LC–MS and Docking Profiling Reveals Potential Difference Between Pure and Crude Fucoidan Metabolites
Authors: Mobashir M**, Mustafa S
Journal: International Journal of Biological Macromolecules
Year: 2020
Impact Factor: 8.025
Title: Developing Sustainable Accounting Framework for Cement Industry: Evidence from India
Authors: Bhat SA et al., Mobashir M
Journal: BMC Genomics, 21:161
Year: 2020
Impact Factor: 4.574
Title: An Approach for Systems-Level Understanding of Prostate Cancer from High-Throughput Data Integration to Pathway Modeling and Simulation
Authors: Mobashir M**, et al.
Journal: Cells
Year: 2022
Impact Factor: 7.666
Title: Multi-Staged Gene Expression Profiling Reveals Potential Genes and Critical Pathways in Kidney Cancer
Authors: Khouja HI et al., Mobashir M**
Journal: Scientific Reports, 12, 7240
Year: 2022
Impact Factor: 4.996
Title: A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy Targeting MARK4 for Hepatocellular Carcinoma
Authors: Ahmed S, Mobashir M**, et al.
Journal: Frontiers in Oncology
Year: 2022
Impact Factor: 5.738
Title: Genomic Profiling and Network-Level Understanding Uncover Potential Genes and Pathways in Hepatocellular Carcinoma
Authors: El-Kafrawy S et al., Mobashir M**
Journal: Frontiers in Genetics
Year: 2022
Impact Factor: 4.599
Title: NF-κB in Signaling Patterns and its Temporal Dynamics Encode/Decode Human Diseases
Authors: Almowallad S, Mobashir M**
Journal: Life
Year: 2022
Impact Factor: 3.251
Title: Synthesis of Silver Nanoparticles Using Myricetin and In-Vitro Assessment of Anti-Colorectal Cancer Activity
Authors: Anwer ST, Mobashir M**, et al.
Journal: International Journal of Molecular Sciences
Year: 2022
Impact Factor: 6.208
Title: Nivolumab and Ipilimumab Acting as Tormentors of Advanced Tumors by Unleashing Immune Cells and Associated Collateral Damage
Authors: Khan B, Mobashir M**
Journal: Pharmaceutics, 16(6), 732
Year: 2024
Impact Factor: 4.9
Note: **Corresponding Author
More Publications: https://scholar.google.se/citations?user=evSOdtYAAAAJ&hl=en
Title: Simulated Evolution of Signal Transduction Networks
Authors: Mobashir M**, Schraven B, Beyer T
Journal: PLOS ONE, 7(12): e50905
Year: 2012
Impact Factor: 3.752
Title: Negative Interactions and Feedback Regulations are Required for Transient Cellular Response
Authors: Mobashir M**, Thati M, Isermann B, Beyer T, Schraven B
Journal: Scientific Reports, 4, 3718
Year: 2014
Impact Factor: 4.996
Title: Pivotal Role of Glycogen Synthase Kinase-3: A Therapeutic Target for Alzheimer’s Disease
Authors: Maqbool M, Mobashir M, Hoda N
Journal: European Journal of Medicinal Chemistry
Year: 2015
Impact Factor: 7.088
Title: Proactive for Invasion: Reuse of Matrix Metalloproteinase for Structural Memory
Authors: Gucciardo E, Mobashir M, Lehti K
Journal: Journal of Cell Biology, 213(1):11–13
Year: 2016
Impact Factor: 10.539
Title: LC–MS and Docking Profiling Reveals Potential Difference Between Pure and Crude Fucoidan Metabolites
Authors: Mobashir M**, Mustafa S
Journal: International Journal of Biological Macromolecules
Year: 2020
Impact Factor: 8.025
Title: Developing Sustainable Accounting Framework for Cement Industry: Evidence from India
Authors: Bhat SA et al., Mobashir M
Journal: BMC Genomics, 21:161
Year: 2020
Impact Factor: 4.574
Title: An Approach for Systems-Level Understanding of Prostate Cancer from High-Throughput Data Integration to Pathway Modeling and Simulation
Authors: Mobashir M**, et al.
Journal: Cells
Year: 2022
Impact Factor: 7.666
Title: Multi-Staged Gene Expression Profiling Reveals Potential Genes and Critical Pathways in Kidney Cancer
Authors: Khouja HI et al., Mobashir M**
Journal: Scientific Reports, 12, 7240
Year: 2022
Impact Factor: 4.996
Title: A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy Targeting MARK4 for Hepatocellular Carcinoma
Authors: Ahmed S, Mobashir M**, et al.
Journal: Frontiers in Oncology
Year: 2022
Impact Factor: 5.738
Title: Genomic Profiling and Network-Level Understanding Uncover Potential Genes and Pathways in Hepatocellular Carcinoma
Authors: El-Kafrawy S et al., Mobashir M**
Journal: Frontiers in Genetics
Year: 2022
Impact Factor: 4.599
Title: NF-κB in Signaling Patterns and its Temporal Dynamics Encode/Decode Human Diseases
Authors: Almowallad S, Mobashir M**
Journal: Life
Year: 2022
Impact Factor: 3.251
Title: Synthesis of Silver Nanoparticles Using Myricetin and In-Vitro Assessment of Anti-Colorectal Cancer Activity
Authors: Anwer ST, Mobashir M**, et al.
Journal: International Journal of Molecular Sciences
Year: 2022
Impact Factor: 6.208
Title: Nivolumab and Ipilimumab Acting as Tormentors of Advanced Tumors by Unleashing Immune Cells and Associated Collateral Damage
Authors: Khan B, Mobashir M**
Journal: Pharmaceutics, 16(6), 732
Year: 2024
Impact Factor: 4.9
Note: **Corresponding Author
More Publications: https://scholar.google.se/citations?user=evSOdtYAAAAJ&hl=en